A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD. Erichsen JM, Register TC, Sutphen C, Ma D, et al. Alzheimers Dement 2025;21:e70704.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Erichsen JM, Register TC, Sutphen C, Ma D, et al. A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD. Alzheimers Dement 2025;21:e70704.
PMID: 41057918